Tokyo Tape
Sign in
← Solasia Pharma

Quarterly report · Q2

4597.TEDINET S100P22B
Period2022-01-01 → 2022-06-30
Filed2022-08-18
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed

Amends S100P1F6.

Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥189m2022-01-01 → 2022-06-30Cons.Revenue IFRS
Revenue¥76m2022-04-01 → 2022-06-30dCons.Revenue IFRS
Revenue¥559m2021-01-01 → 2021-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥278m2021-01-01 → 2021-06-30Cons.Revenue IFRS
Revenue¥186m2021-04-01 → 2021-06-30dCons.Revenue IFRS
Operating income−¥1.2bn2022-01-01 → 2022-06-30Cons.Operating profit loss IFRS
Operating income−¥628m2022-04-01 → 2022-06-30dCons.Operating profit loss IFRS
Operating income−¥1.4bn2021-01-01 → 2021-06-30Cons.Operating profit loss IFRS
Operating income−¥720m2021-04-01 → 2021-06-30dCons.Operating profit loss IFRS
Profit before tax−¥1.2bn2022-01-01 → 2022-06-30Cons.Profit loss before tax IFRS
Profit before tax−¥626m2022-04-01 → 2022-06-30dCons.Profit loss before tax IFRS
Profit before tax−¥2.4bn2021-01-01 → 2021-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥1.4bn2021-01-01 → 2021-06-30Cons.Profit loss before tax IFRS
Profit before tax−¥733m2021-04-01 → 2021-06-30dCons.Profit loss before tax IFRS
Net income (owners)−¥1.2bn2022-01-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥632m2022-04-01 → 2022-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥2.5bn2021-01-01 → 2021-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥1.4bn2021-01-01 → 2021-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥738m2021-04-01 → 2021-06-30dCons.Profit loss attributable to owners of parent IFRS
Net income−¥1.2bn2022-01-01 → 2022-06-30Cons.Profit loss IFRS
Net income−¥632m2022-04-01 → 2022-06-30dCons.Profit loss IFRS
Net income−¥1.4bn2021-01-01 → 2021-06-30Cons.Profit loss IFRS
Net income−¥738m2021-04-01 → 2021-06-30dCons.Profit loss IFRS
Total assets¥3.1bnat 2022-06-30Cons.Assets IFRS
Total assets¥3.1bnat 2021-12-31Cons.Assets IFRS
Total assets¥4.5bnat 2021-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥482mat 2022-06-30Cons.Liabilities IFRS
Total liabilities¥556mat 2021-12-31Cons.Liabilities IFRS
Net assets / equity¥2.6bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥2.6bnat 2021-12-31Cons.Equity IFRS
Net assets / equity¥3.3bnat 2021-06-30Cons.Equity IFRS
Net assets / equity¥3.7bnat 2020-12-31dCons.Equity IFRS
Equity (owners)¥2.6bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥2.6bnat 2021-12-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥3.3bnat 2021-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥973mat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥714mat 2021-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥1.8bnat 2021-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥3.0bnat 2020-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥963m2022-01-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥2.5bn2021-01-01 → 2021-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow−¥1.2bn2021-01-01 → 2021-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥20m2022-01-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥164m2021-01-01 → 2021-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2m2021-01-01 → 2021-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow¥1.2bn2022-01-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥361m2021-01-01 → 2021-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥29m2021-01-01 → 2021-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-8.982022-01-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-4.392022-04-01 → 2022-06-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥-19.042021-01-01 → 2021-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-10.912021-01-01 → 2021-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-5.682021-04-01 → 2021-06-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥-8.982022-01-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-4.392022-04-01 → 2022-06-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥-19.042021-01-01 → 2021-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-10.912021-01-01 → 2021-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-5.682021-04-01 → 2021-06-30dCons.Diluted earnings loss per share IFRS
Equity ratio84.3%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio82.3%at 2021-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio74.1%at 2021-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 548
ItemContextValueUnit
Liabilities and equity IFRSCurrentQuarterInstant3072000000JPY
Revenue IFRSPrior1YTDDuration278000000JPY
Revenue IFRSCurrentYTDDuration189000000JPY
Cost of sales IFRSPrior1YTDDuration157000000JPY
Cost of sales IFRSCurrentYTDDuration61000000JPY
Gross profit IFRSPrior1YTDDuration120000000JPY
Gross profit IFRSCurrentYTDDuration127000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration617000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration347000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration865000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration1008000000JPY
Operating profit loss IFRSPrior1YTDDuration-1362000000JPY
Operating profit loss IFRSCurrentYTDDuration-1228000000JPY
Finance income IFRSPrior1YTDDuration0JPY
Finance income IFRSCurrentYTDDuration2000000JPY
Finance costs IFRSPrior1YTDDuration21000000JPY
Finance costs IFRSCurrentYTDDuration7000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration－JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration-0JPY
Profit loss before tax IFRSPrior1YTDDuration-1383000000JPY
Profit loss before tax IFRSCurrentYTDDuration-1233000000JPY
Income tax expense IFRSPrior1YTDDuration11000000JPY
Income tax expense IFRSCurrentYTDDuration13000000JPY
Profit loss IFRSPrior1YTDDuration-1394000000JPY
Profit loss IFRSCurrentYTDDuration-1247000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration-1394000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration-1247000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration-10.91
Basic earnings loss per share IFRSCurrentYTDDuration-8.98
Diluted earnings loss per share IFRSPrior1YTDDuration-10.91
Diluted earnings loss per share IFRSCurrentYTDDuration-8.98
Revenue IFRSPrior1QuarterDuration186000000JPY
Revenue IFRSCurrentQuarterDuration76000000JPY
Cost of sales IFRSPrior1QuarterDuration115000000JPY
Cost of sales IFRSCurrentQuarterDuration31000000JPY
Gross profit IFRSPrior1QuarterDuration70000000JPY
Gross profit IFRSCurrentQuarterDuration44000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1QuarterDuration359000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentQuarterDuration170000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration431000000JPY
Selling general and administrative expenses IFRSCurrentQuarterDuration503000000JPY
Operating profit loss IFRSPrior1QuarterDuration-720000000JPY
Operating profit loss IFRSCurrentQuarterDuration-628000000JPY
Finance income IFRSPrior1QuarterDuration0JPY
Finance income IFRSCurrentQuarterDuration2000000JPY
Finance costs IFRSPrior1QuarterDuration13000000JPY
Finance costs IFRSCurrentQuarterDuration0JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1QuarterDuration－JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentQuarterDuration-0JPY
Profit loss before tax IFRSPrior1QuarterDuration-733000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2021-12-31pass rounding
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2021-01-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-01-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2021-01-01/2021-06-30pass
statement vs summary · operating cash flowconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-01-01/2021-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-01-01/2022-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2021-12-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass